Using simvastatin to protect the heart during cardiac surgery
Official title: A Study of Simvastatin on Myocardial Protection and Cardiac Function Undergoing Cardiac Surgery With Cardiopulmonary Bypass
Run by Sun Yat-sen University · NCT01653223 · Data updated 2026-11-12
This study tests if simvastatin can help protect the heart and improve recovery for patients having cardiac surgery for heart defects or valve problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 369 (estimated) |
| Sponsor | Sun Yat-sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | January 2013 |
| Main results expected | December 2024 |
| Study ends | December 2026 |
| Registry record updated | April 21, 2023 |
| Trial ID | NCT01653223 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 with congenital heart disease or isolated heart valve disease.
✕Probably not a fit
Patients with coronary artery disease or those allergic to statins will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the myocardial protection effects of simvastatin in patients undergoing cardiac surgery for congenital heart disease and isolated heart valve disease. The research aims to determine whether simvastatin can reduce myocardial injury and improve cardiac function during and after surgery, particularly in cases involving cardiopulmonary bypass. Conducted at two medical centers, this interventional study will assess the long-term benefits of simvastatin postoperatively.
Why it matters
Potential benefit: If successful, this approach could lead to improved heart function and reduced complications for patients undergoing cardiac surgery.
How similar studies have gone: Previous studies have indicated that statins may provide myocardial protection, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * More than 18-year-old, * Congenital heart disease(not complex), * Isolated heart valve disease, Exclusion Criteria: * Coronary artery disease * Allergy for statins * Poor liver function,Hepatitis * Gestation women and Breast-feeding women
Where it's running
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Principal investigator: Jing-song Ou, MD,PhD — The Frist Affiliated Hospital, Sun Yat-sen University
- Study coordinator: Jing-song Ou, MD, PhD
- Email: oujs2000@yahoo.com
- Phone: 8620-87755766
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Prehabilitation before heart surgery for adults with congenital heart disease
This study is testing whether a tailored, supervised exercise program before heart surgery helps adults with congenital heart disease perform better and improve fitness.
-
Serratus Posterior Superior Intercostal Plane Block to Ease Pain After Minimally Invasive Valve Surgery
This study tests whether the SPSIP block with local anesthetic can lower pain and reduce opioid use after minimally invasive heart valve surgery.
-
Accessible care model comparing nurse-led versus physician-led transition education for teens and young adults with congenital heart disease
This project will test whether an accessible care model and nurse-led versus physician-led transition education helps teens and young adults (ages 12–26) with congenital heart disease move successfully from pediatric to adult heart care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.